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Abstract
Tissue-resident macrophages are required for homeostasis, but also contribute to tis-
sue dysfunction in pathophysiological states. The sympathetic neurotransmitter nor-
epinephrine (NE) induces an anti-inflammatory and tissue-reparative phenotype in 
macrophages. As NE has a well-established role in promoting triglyceride lipolysis in 
adipocytes, and macrophages accumulate triglyceride droplets in various physiologi-
cal and disease states, we investigated the effect of NE on primary mouse bone mar-
row-derived macrophage triglyceride metabolism. Surprisingly, our data show that in 
contrast to the canonical role of NE in stimulating lipolysis, NE acting via beta2-adr-
energic receptors (B2ARs) in macrophages promotes extracellular fatty acid uptake 
and their storage as triglycerides and reduces free fatty acid release from triglyceride-
laden macrophages. We demonstrate that these responses are mediated by a B2AR 
activation-dependent increase in Hilpda and Dgat1 gene expression and activity. We 
further show that B2AR activation favors the storage of extracellular polyunsaturated 
fatty acids. Finally, we present evidence that macrophages isolated from hearts after 
myocardial injury, for which survival critically depends on leukocyte B2ARs, have a 
transcriptional signature indicative of a transient triglyceride accumulation. Overall, 
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1 |  INTRODUCTION
Macrophages are innate immune cells that reside in all mam-
malian tissues. In a healthy tissue, macrophages are involved 
in processes related to tissue homeostasis, such as phagocyto-
sis of apoptotic cells and the turnover of extracellular matrix.1 
Moreover, macrophages are essential for the restoration of tissue 
homeostasis following an injury or infection—macrophages are 
rapidly recruited to the site of injury, where their pro-inflam-
matory activation allows the phagocytosis of dying cells and 
invading pathogens. Once the initial insult has been resolved, 
macrophages subsequently acquire an anti-inflammatory phe-
notype that is necessary for wound healing and tissue repair.1 
Such macrophage activity within tissues is tightly regulated by 
a multitude of damage- and pathogen-associated molecules, 
as well as signaling factors from other tissue-resident cells.2 
Abnormal macrophage phenotypes are observed in nearly all 
human pathophysiological states, and macrophages contribute 
to the progression of many diseases, such as type-2 diabetes, 
atherosclerosis, and cancer.3 Therefore, there is a major interest 
in understanding how macrophage behavior is regulated in var-
ious disease states, and whether these regulatory pathways can 
be targeted therapeutically.
One of the regulators of macrophage activity within tis-
sues is the sympathetic nervous system. Sympathetic nerve 
endings within tissues secrete the neurotransmitter norepi-
nephrine (NE) upon firing, which then binds to the adren-
ergic receptors in tissue-resident cells. NE has been shown 
to predominantly signal to macrophages via beta2-adrenergic 
receptor (B2AR).4 In adipose tissues, sympathetic nerve activ-
ity maintains resident macrophages in an anti-inflammatory 
state in a B2AR-signalling dependent manner.5,6 Similarly, 
B2AR activation by sympathetic neurons in the small intes-
tine during enteric infection is critical to drive a tissue-pro-
tective macrophage phenotype.7 The loss of gut sympathetic 
innervation elicits an innate immune system-driven colitis,8 
and the deletion of macrophage B2ARs exacerbates neuronal 
damage following enteric infection.9 Similarly, pharmacolog-
ical blockade of B2AR enhances lipopolysaccharide (LPS)-
induced lung injury in mice.10 Furthermore, B2AR signaling 
in macrophages is necessary for heart repair and survival after 
myocardial infarction.11,12 However, while the NE-B2AR 
signaling axis has been described to play anti-inflammatory 
and tissue-protective roles in macrophages in multiple set-
tings, other potential roles for NE signaling in macrophages 
are yet to be fully investigated.
One of the best-described roles of the sympathetic ner-
vous system in other physiological contexts is the stimulation 
of lipolysis in adipocytes during states of negative energy 
balance, such as fasting.13 NE binding to the adipocyte be-
ta-adrenergic receptors leads to the intracellular activation of 
protein kinase A (PKA), which phosphorylates lipid droplet 
protein perilipin-1.13 Phosphorylated perilipin-1 allows adi-
pose triglyceride lipase (ATGL) to access triglycerides stored 
within lipid droplets and hydrolyze them to release free fatty 
acids (FFAs).13 Therefore, NE has a major role in regulating 
cellular triglyceride metabolism.
Lipid droplet-containing macrophages have been ob-
served in various physiological and pathological states. In 
white adipose tissues, resident macrophages accumulate tri-
glycerides as lipid droplets after fasting- or pharmacologi-
cally induced lipolysis.14,15 Obesity also leads to an increase 
in the population of lipid-laden adipose tissue macrophages, 
which coincides with the development of adipose tissue in-
flammation and insulin resistance.16,17 Similarly, cholester-
ol-rich lipid droplet containing macrophages are found in 
atherosclerotic plaques.18 Furthermore, the accumulation of 
triglyceride-rich lipid droplets in brain-resident macrophages 
(microglia) during aging has been shown to contribute to 
neurodegeneration,19 and increased triglyceride storage in 
tumor-associated macrophages has been linked to cancer pro-
gression.20,21 Finally, macrophage pro-inflammatory activa-
tion by bacterial components and/or interferon-gamma leads 
to increased fatty acid partitioning to triglycerides due to the 
near-complete inhibition of mitochondrial fatty acid oxida-
tion that happens in response to inflammatory activation.22-27
The role of neutral lipid storage in lipid droplets in macro-
phages is not clear. Some reports have shown that increased 
neutral lipid storage by macrophages reduces the intracellu-
lar levels of reactive pro-inflammatory lipid intermediates, 
and thus plays an anti-inflammatory role.20,21,28,29 In support 
of this, macrophage-specific overexpression of the gene-en-
coding Diacylglycerol O-Acyltransferase 1 (DGAT1), which 
catalyzes the final step in triglyceride biosynthesis, alle-
viates adipose tissue inflammation and improves systemic 
insulin sensitivity in mice fed high-fat diet.29 Others have 
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we describe a novel and unexpected role of NE in promoting triglyceride storage in 
macrophages that could have potential implications in multiple diseases.
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demonstrated that lipid droplets can act as reservoirs for pre-
cursor molecules required for pro-inflammatory mediator 
synthesis, and therefore increased macrophage triglyceride 
storage can heighten inflammatory response.30-32 Support for 
the lipid-mediator pool hypothesis comes from data obtained 
from macrophages lacking Hypoxia Inducible Lipid Droplet 
Associated (HILPDA) protein, a potent endogenous inhibi-
tor of ATGL.33 Hilpda-deficient macrophages cannot store 
triglycerides, leading to impaired prostaglandin E2 produc-
tion.30 Reduced prostaglandin secretion in turn translates into 
reduced atherosclerotic plaque size and inflammation in mac-
rophage-specific Hilpda knockout mice compared to controls 
on an ApoE-/- genetic background.30 Finally, it has also been 
shown that triglyceride storage in lipid droplets in activated 
macrophages can be disassociated from their inflammatory 
phenotypes15,34—adipose tissue macrophages isolated from 
high-fat diet-fed macrophage-specific Hilpda knockout mice 
have no lipid droplets, but the development of adipose tissue 
inflammation and insulin resistance in these mice are compa-
rable to controls.34 Notably, while lipid-laden macrophages 
have been identified in multiple physiological and disease 
states, and such lipid accumulation has been either positively 
or negatively linked to disease progression, the endocrine 
and paracrine signaling factors that specifically regulate lipid 
storage in macrophages are yet to be identified.
Given the central role of NE in stimulating triglyceride 
lipolysis in adipocytes, here we investigated the role of ad-
renergic signaling on lipid metabolism in mouse primary 
bone marrow-derived macrophages (BMDMs). We found 
that B2AR activation in BMDMs rapidly upregulated the 
transcription of genes involved in triglyceride biosynthesis, 
namely, Dgat1 and Hilpda. We then showed that B2AR stim-
ulation in macrophages increased the storage of extracellular 
fatty acids as triglycerides, and that this effect was mediated 
by increased DGAT1 activity and by partial ATGL inhibi-
tion, likely due to increased HILPDA expression. Finally, 
we used data from mouse models of heart injury, which is 
characterized by a rapid surge in sympathetic nerve activity35 
and requires macrophage B2ARs for the tissue repair and 
survival.11 We indicated that the transcriptional profile of in-
creased triglyceride storage is also observed in macrophages 
isolated from injured hearts, suggesting that NE-B2AR sig-
naling might contribute to the triglyceride accumulation in 
macrophages in vivo.
2 |  MATERIALS AND METHODS
2.1 | Reagents
All fatty acids and A922500 (10012708) were from Cayman. 
E coli LPS (L4391), (±)-Norepinephrine (+)- bitartrate salt 
(A0937), fenoterol hydrobromide (F1016), bafilomycin 
A1 (B1793), and atglistatin (SML1075) were from Sigma. 
Interleukin-4 (214-14) was from Peprotech. ICI-118,511 
(0821) was from Tocris.
2.2 | Mice
This research has been regulated under the Animals 
(Scientific Procedures) Act 1986 Amendment Regulations 
2012 following ethical review by the University of 
Cambridge Animal Welfare and Ethical Review Body 
(AWERB). Mice used for generation of BMDMs were 
male on a C57Bl/6J genetic background (bred in-house 
or bought from Charles River, UK), used between 8 and 
20  weeks of age. Macrophage-specific Adrb2 knockout 
mouse was generated by crossing a mouse model contain-
ing loxP sequences surrounding Adrb2 alleles (Adrb2fl/fl) 
to the Lyz2-Cre mouse. Adrb2fl/fl mouse was generated 
by Prof. Florent Elefteriou and Prof. Gerard Karsenty as 
described36 and was kindly gifted to us by Prof. Gerard 
Karsenty on a pure C57Bl/6J genetic background. Hilpdafl/
fl and Hilpdafl/fl Lyz2-Cre mice were generated and bred as 
previously described.34
2.3 | Culture of bone marrow–derived 
macrophages
Freshly isolated bone marrow cells were seeded in RPMI-
1640 with 20% L929 conditioned medium (generated as 
described37), 10% heat-inactivated FBS (Gibco, Thermo 
Fisher Scientific), and 100  U/mL penicillin-streptomycin 
(Thermo Fisher Scientific) in 10  cm non-culture treated 
plates (Falcon) at a density of 5 × 106 cells per plate per 
10 mL of medium and cultured for 7 days at 37℃ in 5% 
CO2. Medium was replaced to a fresh one on day 5. On 
day 7, BMDMs were detached using ice-cold PBS con-
taining 1  mM EDTA, seeded in macrophage differentia-
tion medium in cell culture plates (Falcon) at the density 
of 1.35 × 106 cells/cm2, and used for experiments the fol-
lowing day. The cellular identity of BMDMs was routinely 
verified by measuring the expression of macrophage sur-
face markers by flow cytometry as previously described37 
(Figure S1).
2.4 | Cell stimulations
All BMDM stimulations were performed in complete mac-
rophage differentiation medium. Fatty acid treatments were 
done using FFAs conjugated to BSA (A8806, Sigma). 5% 
BSA solution in macrophage differentiation medium was 
conjugated with 2.5  mM fatty acid as described.37 In an 
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experiment involving FFA mixtures, FFAs were conju-
gated to 5% BSA at 5 mM concentration (higher concentra-
tion was chosen to increase the abundance of intracellular 
triglycerides, in order to maximize the signal-to-noise ratio 
for LC-MS detection of triglyceride species or for Oil Red 
O staining). For radiolabeling experiments, 0.006 MBq/mL 
[1-14C]-oleic acid (NEC317050UC, Perkin Elmer) was used 
together with non-labeled oleic acid. For stable labeling ex-
periment, pure [1-13C]-oleic acid (CLM-149, Cambridge 
Isotope Laboratories) was used at an indicated concentra-
tion. In co-stimulation experiments, inhibitors were added 
30-45 minutes prior to B2AR activation or FFA treatment, 
and B2AR agonists were added 5 minutes prior to FFA 
treatment.
2.5 | Extraction of RNA and 
subsequent qPCR
RNA was extracted using Rneasy Plus Mini kit (74106, 
Qiagen) following manufacturers' instructions. Thirty μL of 
RNAse-free water was used for elution. Complementary DNA 
(cDNA) was generated from 250  ng RNA using Promega 
M-MLV reverse transcriptase kit in a 20-μL reaction accord-
ing to manufacturer's instructions. cDNA was diluted 75-fold 
in RNAse-free water and stored at −20°C. qRT-PCR was per-
formed using TaqMan or SYBR Green reagents according to 
manufacturer's instructions (Applied Biosystems). A standard 
curve generated from a pool of all cDNA samples was used for 
quantification. The expression of genes of interest was normal-
ized using BestKeeper method to the geometric average of 3-4 
housekeeping genes (18s, 36b4, Actb, and Tbp), and data were 
expressed as arbitrary units. Primer sequences (5′-3′) used in 
this study are listed in Table 1.
2.6 | RNA sequencing
One µg of total RNA was quality checked (RIN > 8.5) using 
an Agilent Bioanalyser 2100 system and then used to construct 
barcoded sequencing libraries with Illumina's TruSeq Stranded 
mRNA Library Prep Kit following manufacturer's instruction. 
All the libraries where then multiplexed and sequenced on one 
lane of Illumina HiSeq 4000 at SE50 at CRUK Cambridge 
Institute Genomics Core Facility. Sequence reads were mapped 
onto the GRCm38 genome using TopHat v2.0.11 and genes 
were counted using HTseq-count (V0.8.0). Statistical analysis 
of the counts was performed in R (build 3.4.1). Counts were log2 
normalized using Variance Normalization Stabilization (vsn). 
Differential expression analysis was performed using limma li-
brary and pathway analysis was performed using PIANO pack-
ages (used with all base enrichment methods except Wilcoxon, 
with 10 000 permutations if possible). Raw NGS data and a ma-
trix containing raw gene counts have been deposited in GEO, 
accession number GSE16 0640.
2.7 | Western blotting
BMDM protein lysates were subjected to SDS-PAGE 10% 
polyacrylamide electrophoresis (NuPAGE, Thermofisher) 
and transferred onto a nitrocellulose membrane (iBlot, 
Thermofisher) according to manufacturer's protocol. 
Membranes were blocked for 1 hour in 5% milk (Marvel) and 
probed with the following antibodies overnight at 4°C: anti-
CREB (48H2, Cell signaling), anti-P-Ser133 CREB (87G3, 
Cell signaling), and anti-beta-actin (ab8227, Abcam), then 
detected using a peroxidase-coupled secondary anti-rabbit 
antibody (7074, Cell signaling) and enhanced chemilumines-
cence (WBLUF0500, Millipore).
T A B L E  1  qPCR primers used in this study
Gene Forward primer (5′-3′) Reverse primer (5′-3′) Probe (5′-3′)
18s CGGCTACCACATCCAAGGAA GCTGGAATTACCGCGGCT GAGGGCAAGTCTGGTGCCAG
36b4 AGATGCAGCAGATCCGCAT GTTCTTGCCCATCAGCACC
Actb GCTCTGGCTCCTAGCACCAT GCCACCGATCCACACAGAGT ATCAAGATCATTGCTCCTCCT 
GAGCGC
Adrb2 TGGTGGTGATGGTCTTTGTC GTCTTGAGGGCTTTGTGCTC
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2.8 | DGAT activity assay
Microsomes were isolated from 107 BMDMs as described.38 
Briefly, cells were homogenized in 5  mL of homogenizing 
buffer (10 mM Tis-HCl, 0.25 M sucrose, 1 mM EDTA, pH 7.0) 
and centrifuged as follows: 10 minutes at 700 g, 10 minutes 
at 8000 g, and 10 minutes at 17 000 g, all at 4°C. The super-
natant was then transferred to a fresh tube and centrifuged at 
1 05 000 g, 4°C for 45 minutes. The pellet containing micro-
somes was resuspended in 50 μL of 0.1 M Tris-HCl (pH 7.4). 
Microsomal DGAT activity was determined by measuring the 
esterification of palmitoyl-CoA and oleoyl-CoA to sn-1,2-dioc-
tanoylglycerol in the same reaction by GC-MS as described39 
and normalized to total microsomal protein concentration.
2.9 | Oil Red O staining
Oil Red O staining was performed following the standard 
protocol as described.34 In order to quantify the Oil Red O 
staining intensity, images were first adjusted for white bal-
ance, then red channel was isolated, and the percentage of 
dark pixels in the image was quantified after adjusting the 
threshold against the background.
2.10 | Fatty acid oxidation assay
FAO assay was adapted from a published protocol.40 BMDMs 
were treated as described in the legend before washing them 
with PBS and incubating in the presence of FAO medium 
(DMEM containing 12.5  mM HEPES, 1  mM L-carnitine, 
0.3% BSA, and 100 μM oleate with 14C-tracer). Zero h NE 
and etomoxir treatments were performed immediately after 
the medium change. Plates were then immediately sealed 
with parafilm and placed at 37°C for 3 hours. Once the FAO 
reaction finished, 400 μL of the reaction medium was trans-
ferred into the CO2 trapping tubes containing 200 μL of con-
centrated HCl and NaOH-containing paper discs in the lids, 
then incubated for 1 hour at room temperature. 14CO2 was 
detected by measuring the radioactivity in the paper disks by 
liquid scintillation counting.
2.11 | Seahorse mitochondrial stress assay
BMDMs were plated in XF-96 cell culture plates (Agilent) at 
a density of 50 000 cells per well, and the cells were stimu-
lated with 1 μM NE at 1 or 4 hours prior to the assay. Cells 
were washed and the medium change for the XF assay me-
dium (unbuffered DMEM pH 7.4 supplemented with 2 mM 
L-glutamine and 11 mM glucose), then incubated for 1 hour 
in a non-CO2 incubator, following manufacturer instructions. 
Real-time measurement of oxygen-consumption rate (OCR) 
was performed using an XF-96 Extracellular Flux Analyzer 
(Seahorse Bioscience). To assess mitochondrial respiration, 
four consecutive measurements were obtained under basal 
conditions and after the sequential addition of 1 μM oligo-
mycin, to inhibit mitochondrial ATP synthase; 1.5 μM FCCP 
(fluoro-carbonyl cyanide phenylhydrazone), a protonophore 
that uncouples ATP synthesis from oxygen consumption by 
the electron-transport chain; 40 μM Etomoxir, a CPT1a in-
hibitor to inhibit fatty acid oxidation, and 100 nM rotenone 
plus 1 μM antimycin A, which inhibit the electron transport 
chain. All drugs were purchased from Sigma.
2.12 | Lipid extraction
Total lipids from cells were extracted using a modified 
Folch extraction method as described,37 dried under nitro-
gen stream, and stored at −20°C for subsequent processing. 
Neutral lipid fraction was isolated in chloroform using solid-
phase extraction columns (Bond Elut, 12113014, Agilent).
2.13 | Thin-layer chromatography
Dried lipids from 106 BMDMs were solubilized in 50 µL of 
chloroform. Twenty µL of lipids were then spotted at the bottom 
of TLC silica plates (Z292974, Sigma). TLC plates were placed 
into hermetic glass chambers containing one of the following 
solutions: 65:25:4 chloroform:methanol:ammonium hydrox-
ide v/v for phospholipid separation, or 80:20:1 hexane:diethyl 
ether:acetic acid v/v for neutral lipid separation. Plates were 
developed, dried under laminar flow, and incubated with radio-
graphic films (47410, Fujifilm) overnight at room temperature. 
Radiographic films were developed using automated film de-
veloper and scanned. ImageJ software (NIH) was used to calcu-
late the density of the bands on scanned radiograms.
2.14 | [1-13C]-oleic acid detection by GC-MS
Dried neutral lipids from 107 BMDMs were hydrolyzed and 
converted into fatty acid methyl esters, which were then de-
tected by GC (Agilent 7890B) coupled to MS (Agilent 5977A) 
using a TR-FAME column (260M142P, Thermofisher) as 
described.37 1-13C oleate was quantified from an M + 1 ion 
of 12C-oleate-methyl ester (285 m/z).
2.15 | LC-MS lipid analysis
To the previously dried lipid samples, 60 µL of the lipid in-
ternal standard was added (methanol containing CE(18:0)d6, 
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Ceramide(16:0)d31, FA(15:0)d29, LPC(14:0)d42, PA(34:1)
d31, PC(34:1)d31, PE(34:1)d31, PG(34:1)d31, PI(34:1)d31, 
PS(16:0)d62, SM(16:0)d31, TG(45:0)d29, and TG(54:0)d35, 
all at 10  µg/mL). The samples were then thoroughly vor-
texed, then dried under a gentle stream of nitrogen. The sam-
ples were then reconstituted by adding 740 µL of 4:1 mix of 
isopropanol and acetonitrile, respectively, and vortexed en-
suring there was no undissolved material. The samples were 
then analyzed by LC-MS as described.37 The semi-quanti-
tation of the lipids was calculated by the integration of the 
analyte MS signal relative to the lipid class internal standard 
concentration.
2.16 | Statistical analysis
All data from experiments is represented as a mean, with 
error bars showing standard error of the mean and the number 
of replicates stated in the legend. Some data are represented 
as a fold change, and it is stated in legend to what value the 
data represented was normalized to generate the fold change. 
Statistical tests used are also stated in legend. All statisti-
cal tests were performed and graphs were generated using 
GraphPad Prism 6 software. In order to assess similarities 
between RNA sequencing datasets, we used GSEA to see if 
the DEG by fenoterol in BMDMs were significantly enriched 
in the top 500 DEG of a heart injury macrophage dataset, and 
vice versa. Graphs and figures were edited for presentation 
using Adobe Illustrator CC 2015 software.
3 |  RESULTS
3.1 | B2AR stimulation rapidly upregulates 
CREB-dependent gene transcription in 
BMDMs
Prior to investigating the effects of NE on BMDM lipid me-
tabolism, we sought to understand the specificity and kinet-
ics of NE signaling in macrophages. Given the extensive 
literature on the importance of B2AR in macrophage biol-
ogy, we focused on B2AR as the main receptor of NE in 
BMDMs. Indeed, the Adrb2 gene that encodes B2AR was 
the highest expressed adrenergic receptor isoform in mouse 
BMDMs (data not shown). Adrb2 expression was rapidly 
downregulated following stimulation with NE (Figure 1A), 
indicating a negative feedback loop that could act to limit 
further signaling by reducing receptor expression. We then 
focused on B2AR-induced downstream PKA activation. 
One of the best-described PKA phosphorylation targets is a 
transcription factor cAMP response element-binding protein 
(CREB), which activates the transcription of genes with CRE 
sequences in their promoter.41 In order to monitor CREB 
activity, we measured the expression levels of four genes, 
namely, Nr4a1, Klf4, Dusp1, and Ptgs2, that have established 
roles in macrophage biology and are bona fide CREB tar-
gets.41 Stimulating BMDMs with fenoterol, a B2AR-specific 
agonist, rapidly induced the transcription of all four CREB-
dependent genes, with peak expression levels observed 
1 hour post stimulation (Figure 1B).
In order to understand whether NE stimulates gene ex-
pression specifically via B2ARs, we obtained BMDMs 
from macrophage-specific Adrb2 knockout mice. These 
mice had previously been described to have unaltered mac-
rophage development, thus represented a valid model for 
our experiments.9 We observed an almost complete loss of 
Adrb2 expression in Adrb2 knockout BMDMs (Figure 1C). 
Importantly, NE induced the expression of Nr4a1 in WT 
BMDMs in a dose-dependent manner, and this increase 
was almost completely abolished in Adrb2 knockout cells 
(Figure 1D). Finally, we found that fenoterol induced PKA 
activation in WT macrophages, as evidenced by increased 
CREB phosphorylation on PKA target phosphosite Ser133, 
and this activation was abolished in Adrb2 knockout BMDMs 
(Figure  1E). Overall, we found that NE rapidly activated 
CREB-dependent gene transcription in BMDMs in a B2AR-
specific manner.
3.2 | B2AR stimulation upregulates the 
transcription of genes involved in triglyceride 
storage in BMDMs
Having established the specificity and kinetics of NE sign-
aling in BMDMs, we decided to perform global transcrip-
tomic analysis in order to identify transcriptional changes in 
response to fenoterol stimulation. We chose two timepoints 
following B2AR activation—1 hour, representing a peak ex-
pression levels of the upregulated CREB-dependent genes 
(Figure  1B), and 4  hours, representing any potential genes 
with delayed transcriptional activation. RNA sequencing 
analysis of the two timepoints of activation showed two dis-
tinct profiles of transcriptional regulation—at 1 hour, B2AR 
stimulation predominantly resulted in the upregulation of 
gene transcription (Figure 2A), while at 4 hours there were 
comparable numbers of increased and decreased differen-
tially expressed genes (DEGs) (Figure 2B).
Interestingly, further bioinformatic analysis revealed 
that one of the biological pathways upregulated by B2AR 
activation in BMDMs was triglyceride biosynthesis 
(Figure 2C). Biased analysis of top DEGs revealed two can-
didate genes with known roles in triglyceride biosynthesis 
in macrophages—Hilpda (#25 top DEG at 1-hour time-
point, Figure 2A and Table S1) and Dgat1 (#32 top DEG 
at 4-hour timepoint, Figure 2B and Table S2). Of note, the 
Dgat1 gene contains a CRE sequence in its promoter and 
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Dgat1 has been validated as a transcriptional target of 
CREB in myocytes.42
We verified our findings by qPCR in multiple ways. 
Firstly, a time-course of fenoterol stimulation revealed that 
Hilpda was a downstream target of B2AR activation. Hilpda 
expression peaked at 10-fold over baseline at 90  minutes 
post stimulation (Figure 2D). Dgat1 also responded to B2AR 
activation with a 10-fold increase in expression observed at 
2-4 hours post B2AR activation (Figure 2D). Furthermore, 
NE stimulation increased the expression of Hilpda and Dgat1 
in WT BMDMs in a dose-dependent manner, and this ef-
fect was lost in Adrb2-knockout macrophages (Figure  2E). 
Finally, Hilpda and Dgat1 transcriptional activation by NE 
was completely abolished by B2AR-specific antagonist ICI-
118,511 (Figure 2F). Overall, our data were consistent with 
B2AR driving a lipid storage program in BMDMs. We next 
set out to determine the functional relevance of increased 
Dgat1 and Hilpda gene expression.
3.3 | B2AR stimulation promotes the 
uptake and storage of extracellular oleate in 
triglycerides in BMDMs
Initially, we investigated whether B2AR activation increased 
triglyceride biosynthesis in BMDMs. To do so, we stimulated 
F I G U R E  1  NE stimulates CREB-dependent gene expression via B2ARs in BMDMs. A, Adrb2 mRNA levels in BMDMs treated with 1 μM 
NE for indicated periods of time. B, Nr4a1, Klf4, Dusp1, and Ptgs2 mRNA levels in BMDMs treated with 1 μM fenoterol for indicated periods of 
time. C, Adrb2 mRNA levels in BMDMs from Adrb2fl/fl and Lyz2-Cre Adrb2fl/fl mice. D, Nr4a1 mRNA levels in Adrb2fl/fl and Lyz2-Cre Adrb2fl/
fl BMDMs treated with indicated doses of NE or 1 μM fenoterol for 1 h. E, Representative Western blot of indicated proteins in Adrb2fl/fl and 
Lyz2-Cre Adrb2fl/fl BMDMs treated with 1 μM fenoterol for 20 min. All graphs show means ± SEM. N = 4 mice per treatment or genotype in all 
experiments. In D, *indicates P < .05 compared between genotypes using two-way ANOVA with Bonferroni's multiple comparisons test. In A-C, 
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BMDMs with NE and incubated them with stably labeled mon-
ounsaturated fatty acid oleate. Oleate is known to be more read-
ily directed toward triglyceride storage by cultured cells when 
compared to saturated fatty acids such as palmitate.43 Analysis 
of neutral lipids revealed that cells stored similar amounts of 
13C-oleate after 8 and 24 hours of incubation, suggesting that 
BMDMs reached their triglyceride storage capacity limit within 
the first 8 hours of oleate treatment (Figure 3A). Strikingly, NE 
enhanced the amount of 13C-oleate stored in neutral lipids by 
2-fold at 8 hours and by 3-fold at 24 hours of treatment, and 
F I G U R E  2  B2AR activation in BMDMs promotes the transcription of genes involved in triglyceride biosynthesis. Volcano plots indicating 
the differentially expressed genes as blue dots between BMDMs treated with 1 μM fenoterol for A) 1 h or B) 4 h and untreated controls. C, 
‘Reactome_Triglyceride_Biosynthesis' pathway activation status based on the changes in global gene expression between BMDMs treated with 
1 μM fenoterol for 1 h and untreated controls. D, Hilpda and Dgat1 mRNA levels in BMDMs treated with 1 μM fenoterol for indicated periods 
of time. E, Hilpda and Dgat1 mRNA levels in Adrb2fl/fl and Lyz2-Cre Adrb2fl/fl BMDMs treated with indicated doses of NE or 1 μM fenoterol 
for 1 h (Hilpda) or 4 h (Dgat1). F, Hilpda and Dgat1 mRNA levels in BMDMs treated with 1 μM NE in the presence or absence of 1 μM B2AR 
antagonist ICI-118,511 for indicated periods of time. All graphs show means ± SEM. N = 4 mice per treatment or genotype in all experiments. 
In E, *indicates P < .05 compared between genotypes using two-way ANOVA with Bonferroni's multiple comparisons test. In D, F, significant 
differences were not assessed
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F I G U R E  3  B2AR activation promotes extracellular oleate storage as triglycerides in macrophages in a DGAT1-dependent manner. A, 
GC-MS quantification of 13C-oleate in the neutral lipid fraction of BMDMs stimulated with 1 μM NE in the presence or absence of 1 μM B2AR 
antagonist ICI-118,511 and treated with 250 μM 13C-oleate for 8 and 24 h. Values are normalized to the 13C-oleate amount in the neutral lipid 
fraction of unstimulated cells after 8 h of oleate loading. B, DGAT activity in the microsomal fraction of BMDMs stimulated with 100 ng/mL LPS 
or 10 μM IL-4 for 24 h, or 1 μM NE for 8 or 24 h, using palmitoyl-CoA or oleoyl-CoA as a substrate, expressed as fold change from untreated cells. 
C, Oleate uptake by BMDMs, stimulated with 1 μM fenoterol, 1 μM NE, 1 μM B2AR antagonist ICI-118,511, 1 μM DGAT1 inhibitor A922500, 
as indicated on the graph, or treated with 250 μM oleate in the presence of 14C-oleate tracer for 16 h. Oleate uptake is expressed as a fold change 
in specific activity of stimulated cells from unstimulated controls. D, Representative areas of thin-layer chromatography plate autoradiograms of 
separated neutral or polar lipids (from the same total lipid samples) isolated from BMDMs stimulated with 1 μM fenoterol and 1 μM A922500 as 
indicated, then treated with 100 μM oleate containing 14C-oleate tracer for 16 h. Graph shows the quantification of TG band intensities, normalized 
to the intensity of untreated vehicle group. All graphs show means ± SEM. N = 4 mice in all experiments. In A, C, D, *indicates P < .05 compared 
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this effect could be blocked by ICI-118,511, indicating that 
B2AR activation increased triglyceride storage in BMDMs 
(Figure 3A). In line with these findings, NE treatment increased 
DGAT activity in BMDM microsomes both at 8 and 24 hours 
post B2AR activation (Figure  3B). Interestingly, increased 
DGAT activity was specific to NE, as neither pro-inflammatory 
activation by LPS nor anti-inflammatory activation by interleu-
kin-4 (IL-4)-modulated microsomal DGAT activity in BMDMs 
(Figure 3B). Of note, DGAT activity in BMDM microsomes in 
vitro could be completely blocked in the presence of DGAT1-
specific inhibitor A922500 (DGAT1i), indicating that DGAT1 
is the predominant DGAT isoform in BMDMs (Figure S2).
We then addressed the importance of increased DGAT1 ac-
tivity on the uptake and storage of oleate in BMDMs. DGAT1i 
treatment reduced the total oleate uptake by BMDMs by 2-fold 
over 16 hours of incubation, suggesting that fatty acid esterifi-
cation to triglycerides is one of the main processes driving ex-
tracellular fatty acid influx to BMDMs (Figure 3C). Similarly, 
B2AR activation increased the total oleate uptake by 1.5-fold, 
and this increase was markedly diminished in the presence of 
DGAT1i (Figure 3C). Furthermore, tracing the flux of radio-
label revealed that while oleate was readily incorporated in 
triglycerides and all major phospholipid classes in BMDMs, 
B2AR selectively increased oleate flux to triglycerides without 
affecting the radiolabeling of other lipid species, and inhibit-
ing DGAT1 activity blocked most of the triglyceride storage 
in BMDMs (Figure 3D). Altogether, our results showed that 
B2AR activation elevated DGAT1 activity, which increased 
oleate uptake and storage as triglycerides in BMDMs.
3.4 | B2AR stimulation reduces the rate of 
triglyceride lipolysis by HILPDA-dependent 
inhibition of ATGL activity in BMDMs
Next, we sought to address the role of B2AR-mediated 
Hilpda transcriptional activation in promoting triglyceride 
storage in BMDMs. Given that HILPDA is an endogenous 
ATGL inhibitor,33 we designed a lipolysis assay that allowed 
us to assess the contribution of different lipolytic pathways to 
FFA release in BMDMs. We first loaded BMDMs overnight 
with oleate (containing radiolabeled tracer), then washed the 
cells, changed the medium, immediately stimulated the cells 
with B2AR agonists, and monitored the release of radiolabel 
into the fresh medium. B2AR activation resulted in a reduced 
rate of intracellular oleate release into the medium, and this 
could be reversed by B2AR antagonism (Figure 4A).
We then investigated whether DGAT1-mediated FFA 
re-esterification, or autophagic degradation of lipid drop-
lets (lipophagy),44 could explain the reduced oleate release 
into the media following B2AR activation in BMDMs. We 
found that inhibiting DGAT1 increased, while blocking au-
tophagy with bafilomycin A1 reduced the oleate release 
rate in BMDMs (Figure  S3A and B). However, both in-
hibitors remained effective in suppressing the lipolysis in 
B2AR agonist-treated macrophages (DGAT1i interaction P 
value = .104, Baf A1 interaction P value = .316, Figure S3A 
and B), indicating that B2AR agonists reduced oleate release 
neither by regulating fatty acid re-esterification nor lipoph-
agy. Of all compounds tested, we observed the strongest 
inhibitory effect on BMDM lipolysis using ATGL-specific 
inhibitor atglistatin (Figure 4B). Importantly, atglistatin did 
not inhibit lipolysis further in fenoterol-treated macrophages, 
suggesting that B2AR activation decreased the rate of lip-
olysis in BMDMs by suppressing ATGL activity (Figure 4B, 
interaction P value <.0001).
In order to demonstrate whether HILPDA was responsible 
for the inhibition of ATGL activity and increased triglyceride 
retention in B2AR agonist-treated macrophages, we obtained 
BMDMs from macrophage-specific Hilpda knockout mice. 
Similar to the previous reports,30,34 we observed a strongly 
impaired capacity for Hilpda-deficient macrophages to accu-
mulate lipid droplets in the presence of exogenous fatty acids 
(Figure 4C and D, S4). Importantly, while B2AR activation 
by NE increased the neutral lipid stores in control BMDMs 
loaded with fatty acids for both 6 and 16 hours, this increase 
was largely diminished in macrophages lacking Hilpda 
(Figure 4C and D), indicating that elevated Hilpda expression 
in response to B2AR activation contributes to the increased 
triglyceride storage in macrophages.
Lastly, we investigated whether the B2AR-mediated sup-
pression of triglyceride lipolysis also affected fatty acid oxi-
dation in macrophages. Indeed, we observed a small decrease 
in the oxidation of exogenous oleate in NE-treated BMDMs 
(Figure  4E). However, B2AR activation did not affect the 
mitochondrial respiration in macrophages, suggesting that 
decreased oleate oxidation in response to NE treatment was 
not due to changes in mitochondrial function (Figure  4F). 
Overall, we found that B2AR activation suppressed macro-
phage ATGL-dependent lipolysis by upregulating Hilpda 
expression.
3.5 | B2AR stimulation favors the increase 
in the synthesis rate of polyunsaturated fatty 
acid-containing triglycerides
So far, all our conclusions relied on experiments involv-
ing labeled oleate measurements. In order to demonstrate 
whether B2AR activation increased BMDM triglyceride 
storage independently of the type of exogenous fatty acid 
used as a substrate, we formulated a complex FFA mix-
ture that had similar ratios of FFAs released from WAT in 
response to fasting in vivo (Figure  5A). We then treated 
BMDMs with fenoterol for 2 and 6  hours in the presence 
of FFA mixture and performed lipidomic analysis to reveal 
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global changes in BMDM lipid species induced by B2AR 
activation. Interestingly, we found that fenoterol treatment 
did not modulate overall triglyceride levels in BMDMs in 
the absence of FFA treatment (Figure 5B), suggesting that el-
evated extracellular FFA concentrations are required for the 
B2AR-mediated increase in triglyceride storage (note that 
all treatments were performed in the media supplemented 
with 10% fetal bovine serum that contains FFAs). Indeed, in 
line with our previous data obtained using oleate, treatment 
with FFA mixture increased BMDM triglyceride storage in 
a time-dependent manner, which was accelerated further in 
fenoterol-treated cells (Figure 5B).
Analysis of individual lipid species revealed that while 
the treatment with FFA mixture affected the abundance of 
I G U R E  4  FB2AR activation reduces the rate of oleate release from triglyceride-laden macrophages by HILPDA-dependent ATGL inhibition. 
A, Fractional oleate release into the medium by BMDMs, preloaded with 250 μM oleate in the presence of 14C-oleate tracer for 16 h, at indicated 
timepoints post medium change. Cells were pretreated with inhibitors 30 min before medium change (inhibitor concentration in the medium was 
maintained post change) and treated with B2AR agonists immediately after medium change, as indicated on the graphs: A) 1 μM NE, 1 μM B2AR 
antagonist ICI-118,511; B) 1 μM fenoterol; 20 μM ATGL inhibitor Atglistatin. C, Representative Oil Red O images of Hilpdafl/fl and Lyz2-
Cre Hilpdafl/fl BMDMs (n = 3/group), treated with 600 μM palmitate:oleate mixture for 6 or 16 h, in the presence or absence of 10 μM NE. D, 
Quantification of Oil Red O staining intensity. E, Oleate oxidation, assessed over 3 h in cells pretreated with 1 μM NE for indicated periods of time, 
or in the presence of 40 μM mitochondrial fatty acid oxidation inhibitor etomoxir. F, Mitochondrial stress Seahorse assays of BMDMs treated with 
1 μM NE for 1 or 4 h prior to the assay. All graphs show means ± SEM. N = 4 mice in all WT experiments. In A, *indicates P < .05 compared 
between B2AR agonist treatments using two-way ANOVA with Bonferroni's multiple comparisons test. In B) area under curve graphs, a indicates 
P < .05 for B2AR agonist effect factor, b indicates P < .05 for inhibitor effect factor, and a*b indicates P < .05 for interaction between both factors 
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F I G U R E  5  B2AR activation favors the synthesis of PUFA-rich triglycerides in macrophages during the incubation with a complex FFA 
mixture. A, Fatty acid composition of the mixture used in the experiment. B, Sum of areas under curve of all triglyceride species measured by 
LC-MS in BMDMs treated with 0.5% BSA alone or 500 μM of FFA mixture conjugated to 0.5% BSA for 2 or 6 h, in the presence or absence of 
1 μM fenoterol as indicated. C, Heatmap of areas under curve of each measured triglyceride species in BMDMs treated with FFA mixture for 2 
or 6 h, in the presence or absence of 1 μM fenoterol as indicated (BSA alone treatment is not shown). D, Fold change in the abundance of each 
measured triglyceride species between BMDMs treated with 1 μM fenoterol and untreated controls in the presence of FFA mix for 2 or 6 h. E, 
Linear regression plots of fold change in the abundance of each measured triglyceride species between BMDMs treated with 1 μM fenoterol and 
untreated controls plotted against the number of double bonds in the respective triglyceride molecule, at either 2 or F) 6 h of incubation. All graphs 
show means ± SEM. N = 4 mice in all experiments. In B-D, significant differences were not assessed. In E, F, R2 and P values of linear regression 
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several phospholipid species, B2AR activation did not mod-
ulate the level of any measured PC, PE, or DAG species in 
BMDMs, either in the presence or absence of FFA mixture 
(Figure  S5). In contrast, fenoterol treatment enhanced the 
accumulation of nearly all measured triglyceride species in 
BMDMs treated with FFA mixture at both 2- and 6-hour 
timepoints (Figure 5C and D). Interestingly, while at 2 hours 
fenoterol increased the accumulation of most measured tri-
glyceride species in a uniform manner (Figure 5D and E), at 
6 hours the increase was disproportionately shifted toward the 
storage of polyunsaturated fatty acid-containing triglycerides 
(Figure 5D,F). In general, we found that B2AR activation in-
creased triglyceride storage in BMDMs only in the presence 
of elevated extracellular FFA concentrations, that it did not 
affect the levels of measured phospholipid species, and that it 
preferentially increased the synthesis rate of polyunsaturated 
fatty acid-containing triglycerides.
3.6 | Macrophages isolated from injured 
hearts have a transcriptional profile 
indicative of increased triglyceride storage
Finally, we sought to understand whether B2AR activation-
mediated transcriptional changes in triglyceride biosynthe-
sis genes are observed in macrophages in vivo. We chose 
to investigate macrophages isolated from injured hearts for 
the following reasons: (i) Heart injury increases sympa-
thetic nerve activation in the heart, leading to elevated NE 
levels35; (ii) Macrophage B2ARs are necessary for survival 
post injury,11 indicating that B2AR-dependent processes in 
macrophages are required for heart repair; (iii) The transcrip-
tomic analyses of heart macrophages isolated from multiple 
different mouse models of heart injury are available45-48; 
(iv) Recent single-cell RNAseq analysis revealed that ‘lipid 
transport’ was the most upregulated pathway in heart mac-
rophages in response to myocardial infarction.47 We found 
that both myocardial cryoinjury45 and diphtheria toxin-medi-
ated ablation of cardiomyocytes46 resulted in downregulated 
Adrb2 levels in heart macrophages at 2-4  days post injury 
(Figure 6A and B), similar to reduced Adrb2 expression in 
response to NE in BMDMs (Figure 1A). We then analyzed 
the expression of our top RNAseq DEGs (Figure 2A and B, 
Tables S1 and S2) in both heart macrophage datasets. We ob-
served that all genes that were highly upregulated in response 
to fenoterol stimulation in BMDMs were also increased in 
heart macrophages acutely after heart injury (Figure 6A and 
B). Importantly, the expression of triglyceride storage mark-
ers Dgat1, Dgat2 (DGAT isoform that has high gene ex-
pression levels in heart macrophages, relative to other tissue 
macrophages, according to Immgen.com), Hilpda, and Plin2 
(encoding Adipose differentiation-related protein, a marker 
for cellular lipid droplet accumulation49) was also increased 
in cardiac macrophages in response to injury (Figure 6A and 
B), indicating that heart injury in vivo drives a similar tri-
glyceride storage program in macrophages as NE stimulation 
in vitro. Finally, statistical comparison of global transcrip-
tomic changes induced by NE in vitro to heart injury in vivo 
revealed a high similarity between the B2AR activation in 
BMDMs and heart macrophages at 3 days post injury, which 
was no longer observed at 7  days post injury (Figure  6C). 
Altogether, we found that myocardial injury, associated with 
elevated sympathetic nervous system activity in the heart, 
increased the transcription of genes involved in triglyceride 
biosynthesis in macrophages, suggesting that our described 
NE-B2AR pathway could also increase triglyceride storage 
in macrophages in vivo.
4 |  DISCUSSION
Here, we demonstrate that the sympathetic neurotransmitter 
NE increases triglyceride storage in mouse BMDMs by ac-
tivating B2AR. We show that these effects are mediated by 
the upregulated expression of two genes: Dgat1, leading to 
increased triglyceride biosynthesis; and Hilpda, leading to a 
partial ATGL inhibition and decreased triglyceride lipolysis. 
Our study is the first to link NE-B2AR signaling to changes 
in macrophage lipid metabolism, namely, to the increased tri-
glyceride storage.
Previous studies have shown that pro-inflammatory 
activation leads to triglyceride accumulation in macro-
phages.22-27 The precise mechanisms leading up to in-
creased triglyceride storage following the stimulation of 
macrophages with bacterial components have not been 
fully elucidated. However, it has been suggested that de-
creased lipolysis,23,25 decreased fatty acid oxidation,27 
or a reduction in extracellular pH24 could be involved. 
Importantly, pro-inflammatory macrophage activation is 
accompanied by dramatic changes in macrophage metabo-
lism, including increased glycolysis and phospholipid bio-
synthesis, and decreased fatty acid oxidation.50 In contrast, 
our data indicate that B2AR activation in BMDMs specif-
ically increases triglyceride storage only in the presence of 
elevated extracellular fatty acid levels, and without affect-
ing either the levels or the fatty acid composition of other 
cellular lipid species. Furthermore, while B2AR activation 
partially suppressed exogenous fatty acid oxidation, it did 
not inhibit mitochondrial oxidative metabolism, which is 
a common feature of pro-inflammatory macrophage acti-
vation.51 The decrease in exogenous oleate oxidation fol-
lowing B2AR stimulation was consistent with an increased 
fatty acid flux toward lipid droplets and away from mito-
chondria. Lastly, we find that DGAT activity is not affected 
by macrophage inflammatory activation (Figure 3B), sug-
gesting that the mechanisms leading to triglyceride storage 
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in response to B2AR activation in macrophages are mech-
anistically distinct from those observed in response to 
stimulation with bacterial components. Therefore, to our 
knowledge, NE-B2AR signaling axis is the first reported 
pathway that specifically modulates macrophage triglycer-
ide metabolism.
F I G U R E  6  Macrophages isolated from injured hearts have a transcriptional signature indicative of B2AR activation and increased triglyceride 
storage. A, Heatmaps showing the expression levels of indicated genes measured in macrophages isolated from mice subjected to myocardial 
cryoinjury model at indicated periods following the injury. Expression levels are normalized to macrophages from healthy hearts (day 0). 
N = 3 mice/group. Data were obtained from Walter et al B, Heatmaps showing the expression levels of indicated genes measured in indicated 
macrophage populations isolated from mice with cardiomyocyte-specific expression of diphtheria toxin receptor at indicated periods following the 
administration of diphtheria toxin. Expression levels are normalized to CCR2-Flt-macrophages from healthy hearts (day 0). N = 2-4 mice/group. 
Experimental data generated by Bajpai et al were obtained from Immgen.com. C, Statistical comparison of global transcriptomic changes induced 
by fenoterol stimulation in BMDMs in vitro (this study, normalized to unstimulated controls) to changes induced by myocardial cryoinjury in vivo 
(Walter et al, normalized to Day 0 macrophages). Lower P value indicates higher similarities of changes between two datasets. In A, B, statistical 
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We have also found that B2AR activation preferentially 
increased the storage of polyunsaturated fatty acid-contain-
ing triglycerides. While we do not provide a mechanistic ex-
planation for this observation, a recent study has found that 
increased HILPDA expression enriches cancer cells in poly-
unsaturated fatty acid-containing triglycerides.52 Therefore, 
it is plausible that it is the increased HILPDA expression that 
mediates our observed phenotype in macrophages. In future, 
it would be of interest to investigate the precise molecular 
mechanism of how HILPDA modulates the profile of cellular 
triglyceride species.
The main limitation of our study is the lack of direct ex-
perimental evidence that NE-B2AR is involved in regulating 
triglyceride metabolism in macrophages in vivo. However, 
there are multiple physiological and disease settings where 
increased tissue sympathetic nerve activity coincides with the 
accumulation of lipid droplets in tissue macrophages. During 
aging, sympathetic nerve activity is increased in the brain, as 
evidenced by higher brain NE turnover.53 The aging brain is 
also characterized by the presence of lipid droplet-containing 
microglia, which have been shown to promote neurodegen-
eration.19 Interestingly, triglyceride-laden microglia isolated 
from aging brains also exhibits downregulated Adrb2 expres-
sion,19 which can be a marker of increased B2AR activation, 
as we have shown here (Figure  1A). Furthermore, fasting 
promotes sympathetic nerve firing in white adipose tissues, 
which leads to adipocyte lipolysis, but lipid droplet accumu-
lation in adipose tissue macrophages.14,15 Finally, our analy-
ses suggest that heart macrophages accumulate triglycerides 
in response to heart injury (Figure 6), which is also charac-
terized by increased sympathetic nerve activity.35 Two recent 
single-cell RNAseq analyses also show similar findings—
one revealed a population of lipid-associated macrophages 
in the heart post injury,48 while the other demonstrated that 
myocardial infarction upregulates lipid transport pathways in 
cardiac macrophages.47 While the involvement of B2AR in 
these processes is currently speculative, we believe that there 
is a firm basis to investigate the relationship between B2AR 
activation and lipid-laden macrophage formation in vivo in 
future using cell type-specific Adrb2 KO mice.
We also did not address the biological importance of the 
NE signaling-dependent increase in macrophage triglyceride 
storage. However, we speculate that it might have different 
physiological outcomes, depending on the context. For ex-
ample, heart tissue is enriched in polyunsaturated fatty ac-
id-containing phospholipids.54 Furthermore, heart injury is 
characterized by elevated reactive oxygen species (ROS).55 
As polyunsaturated fatty acids are selectively released from 
apoptotic cells,56 and ROS can rapidly oxidize them, seques-
tering polyunsaturated fatty acids within lipid droplets may 
protect them from peroxidation and subsequent lipotoxicity.57 
Intriguingly, systemic atglistatin treatment has already been 
shown to improve the recovery from heart failure in mice.58 
While these effects were originally attributed to inhibited 
adipose tissue lipolysis,35,58 it is tempting to speculate that 
atglistatin-mediated increase in triglyceride storage in mac-
rophages could also be beneficial for cardiac repair. In fu-
ture, it would be interesting to investigate such hypothesis 
by subjecting macrophage-specific Dgat1 or Hilpda knock-
out mice (macrophages from both models exhibit defects in 
triglyceride storage) to myocardial injury, and assessing their 
recovery.
Alternatively, adipose tissue macrophages have been sug-
gested to buffer local fatty acid levels released from adipo-
cytes during lipolysis.14,59 It is therefore plausible that NE 
can simultaneously promote fatty acid release from adipo-
cytes and fatty acid storage in adipose tissue macrophages, 
ensuring an efficient lipolytic response without subjecting 
white adipose tissue-resident cells to lipotoxic FFA con-
centrations. Furthermore, a preference toward the storage of 
essential polyunsaturated fatty acids in adipose tissue mac-
rophages might be a physiological mechanism that lowers 
the polyunsaturated fatty acid efflux from the adipose tissue 
during fasting, limit their oxidation in other tissues, and thus 
preserve systemic stores. Overall, future studies are war-
ranted to investigate the importance of NE-B2AR signaling 
in various physiological and pathological settings.
Finally, it is likely that the B2AR pathway we describe 
here is involved in regulating triglyceride storage in other cell 
types as well. B2AR agonists increase hepatic lipid accumula-
tion in mice through a mechanism that is independent of white 
adipose tissue lipolysis.60 Age-related hepatic triglyceride ac-
cumulation is attenuated in Adrb2 knockout animals,61 while 
overexpressing Adrb2 in hepatocytes promotes hepatoste-
atosis.60 Furthermore, NE released during intensive exercise 
regulates myofiber remodeling in skeletal muscle, a process 
associated with a CREB-dependent increase in DGAT1 ac-
tivity and elevated storage of intramuscular triglycerides.42 
Lastly, while NE released during fasting activates lipolysis 
in white adipocytes, it also increases their DGAT1 activity 
and fatty acid re-esterification, which has been reported to 
protect adipocytes from endoplasmic reticulum and lipotoxic 
stresses.62 Even though NE is classically viewed as a cata-
bolic neurotransmitter, we believe that it also has an anabolic 
role in many cell types, including macrophages.
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